In a recent study by Cabel et al. [27], the presence of ctDNA was evaluated during treatment with an immune checkpoint blocker in 15 cancer patients including 10 NSCLC patients, whereof 2 had an EGFR mutation (L858R). Here, EGFR is linked to non-small cell lung carcinoma.